In the rapidly evolving landscape of American healthcare, ivermectin—a decades-old antiparasitic drug—is facing a future shaped not just by medical science, but by policy and technology. As 2025 unfolds, two powerful forces dominate the ivermectin narrative: budget-tightening Medicaid reforms and the artificial intelligence (AI) revolution in clinical...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek